-
1
-
-
66949152096
-
Parkinson’s disease
-
COI: 1:CAS:528:DC%2BD1MXnt1ans7w%3D, PID: 19524782
-
Lees AJ, Hardy J, Revesz T (2009) Parkinson’s disease. Lancet 373(9680):2055–2066
-
(2009)
Lancet
, vol.373
, Issue.9680
, pp. 2055-2066
-
-
Lees, A.J.1
Hardy, J.2
Revesz, T.3
-
2
-
-
0020375803
-
Basal ganglia disease
-
COI: 1:CAS:528:DyaL3sXktVemurk%3D, PID: 6128460
-
Marsden CD (1982) Basal ganglia disease. Lancet 2(8308):1141–1147
-
(1982)
Lancet
, vol.2
, Issue.8308
, pp. 1141-1147
-
-
Marsden, C.D.1
-
3
-
-
0026348872
-
Pathology of Parkinson’s disease
-
Jellinger KA (1991) Pathology of Parkinson’s disease. Mol Chem Neuropathol 3:153–197
-
(1991)
Mol Chem Neuropathol
, vol.3
, pp. 153-197
-
-
Jellinger, K.A.1
-
4
-
-
2542596183
-
Parkinson’s disease
-
COI: 1:CAS:528:DC%2BD2cXksVanu7k%3D, PID: 15172778
-
Samii A, Nutt JG, Ransom BR (2004) Parkinson’s disease. Lancet 363(9423):1783–1793
-
(2004)
Lancet
, vol.363
, Issue.9423
, pp. 1783-1793
-
-
Samii, A.1
Nutt, J.G.2
Ransom, B.R.3
-
5
-
-
0033836912
-
Motor impairment in Parkinson’s disease: relationship to incident dementia and age
-
COI: 1:STN:280:DC%2BD3cvhsV2qug%3D%3D, PID: 10953188
-
Levy G, Tang MX, Cote LJ, Louise ED, Alfaro B, Mejia H, Stern Y, Marder K (2000) Motor impairment in Parkinson’s disease: relationship to incident dementia and age. Neurology 55:539–544
-
(2000)
Neurology
, vol.55
, pp. 539-544
-
-
Levy, G.1
Tang, M.X.2
Cote, L.J.3
Louise, E.D.4
Alfaro, B.5
Mejia, H.6
Stern, Y.7
Marder, K.8
-
6
-
-
0030271126
-
Basal ganglia and movement disorders: an update
-
Chesselet MF, Delfs JM (1999) Basal ganglia and movement disorders: an update. Trends Neurosci 19:417–422
-
(1999)
Trends Neurosci
, vol.19
, pp. 417-422
-
-
Chesselet, M.F.1
Delfs, J.M.2
-
7
-
-
0038727939
-
Physiology and pathophysiology of Parkinson’s disease
-
PID: 12846970
-
Hamani C, Lozano AM (2003) Physiology and pathophysiology of Parkinson’s disease. Ann NY Acad Sci 991:15–21
-
(2003)
Ann NY Acad Sci
, vol.991
, pp. 15-21
-
-
Hamani, C.1
Lozano, A.M.2
-
8
-
-
84867337416
-
Positron emission tomography imaging in neurological disorders
-
PID: 22297461
-
Politis M, Piccini P (2012) Positron emission tomography imaging in neurological disorders. J Neurol 259(9):1769–1780
-
(2012)
J Neurol
, vol.259
, Issue.9
, pp. 1769-1780
-
-
Politis, M.1
Piccini, P.2
-
9
-
-
0034241796
-
Positron emission tomography provides molecular imaging of biological processes
-
COI: 1:CAS:528:DC%2BD3cXls12ksb8%3D, PID: 10922074
-
Phelps ME (2000) Positron emission tomography provides molecular imaging of biological processes. PNAS 97:9226–9233
-
(2000)
PNAS
, vol.97
, pp. 9226-9233
-
-
Phelps, M.E.1
-
10
-
-
0022929679
-
Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography
-
COI: 1:CAS:528:DyaL2sXosVekug%3D%3D, PID: 3027000
-
Halldin C, Stone-Elander S, Farde L, Ehrin E, Fasth KJ, Långström B, Sedvall G (1986) Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography. Int J Rad Appl Instrum A 37(10):1039–1043
-
(1986)
Int J Rad Appl Instrum A
, vol.37
, Issue.10
, pp. 1039-1043
-
-
Halldin, C.1
Stone-Elander, S.2
Farde, L.3
Ehrin, E.4
Fasth, K.J.5
Långström, B.6
Sedvall, G.7
-
11
-
-
34748858652
-
[11C]NNC 112 selectivity for dopamine D1 and serotonin 5-HT(2A) receptors: a PET study in healthy human subjects
-
COI: 1:CAS:528:DC%2BD2sXhtVKhtrjE, PID: 17311076
-
Slifstein M, Kegeles LS, Gonzales R, Frankle WG, Xu X, Laruelle M, Abi-Dargham A (2007) [11C]NNC 112 selectivity for dopamine D1 and serotonin 5-HT(2A) receptors: a PET study in healthy human subjects. J Cereb Blood Flow Metab 27(10):1733–1741
-
(2007)
J Cereb Blood Flow Metab
, vol.27
, Issue.10
, pp. 1733-1741
-
-
Slifstein, M.1
Kegeles, L.S.2
Gonzales, R.3
Frankle, W.G.4
Xu, X.5
Laruelle, M.6
Abi-Dargham, A.7
-
12
-
-
0032881922
-
A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain
-
COI: 1:CAS:528:DyaK1MXntlOmtbg%3D, PID: 10525759
-
Chou YH, Karlsson P, Halldin C, Olsson H, Farde L (1999) A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain. Psychopharmacology 146(2):220–227
-
(1999)
Psychopharmacology
, vol.146
, Issue.2
, pp. 220-227
-
-
Chou, Y.H.1
Karlsson, P.2
Halldin, C.3
Olsson, H.4
Farde, L.5
-
13
-
-
0026281594
-
Positron emission tomography of brain dopamine D-1 receptors with 11C-SCH 23390 in Parkinson’s disease
-
COI: 1:STN:280:DyaK383hsVWkuw%3D%3D, PID: 1666760
-
Rinne JO, Laihinen A, Någren K, Bergman J, Haaparanta M, Solin O, Ruotsalainen U, Rinne UK (1991) Positron emission tomography of brain dopamine D-1 receptors with 11C-SCH 23390 in Parkinson’s disease. Acta Radiol Suppl 376:152
-
(1991)
Acta Radiol Suppl
, vol.376
, pp. 152
-
-
Rinne, J.O.1
Laihinen, A.2
Någren, K.3
Bergman, J.4
Haaparanta, M.5
Solin, O.6
Ruotsalainen, U.7
Rinne, U.K.8
-
14
-
-
0032752306
-
Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson’s disease: a double-tracer positron emission tomography study
-
COI: 1:STN:280:DC%2BD3c%2FhvFCitQ%3D%3D, PID: 10553989
-
Ouchi Y, Kanno T, Okada H, Yoshikawa E, Futatsubashi M, Nobezawa S, Torizuka T, Sakamoto M (1999) Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson’s disease: a double-tracer positron emission tomography study. Ann Neurol 46(5):723–731
-
(1999)
Ann Neurol
, vol.46
, Issue.5
, pp. 723-731
-
-
Ouchi, Y.1
Kanno, T.2
Okada, H.3
Yoshikawa, E.4
Futatsubashi, M.5
Nobezawa, S.6
Torizuka, T.7
Sakamoto, M.8
-
15
-
-
0035809803
-
Dopamine D(1) receptor expression in human basal ganglia and changes in Parkinson’s disease
-
COI: 1:CAS:528:DC%2BD3MXhs1eisLg%3D, PID: 11245931
-
Hurley MJ, Mash DC, Jenner P (2001) Dopamine D(1) receptor expression in human basal ganglia and changes in Parkinson’s disease. Brain Res Mol Brain Res 87(2):271–279
-
(2001)
Brain Res Mol Brain Res
, vol.87
, Issue.2
, pp. 271-279
-
-
Hurley, M.J.1
Mash, D.C.2
Jenner, P.3
-
16
-
-
0027264960
-
Dopamine D1 receptors in Parkinson’s disease and striatonigral degeneration: a positron emission tomography study
-
COI: 1:STN:280:DyaK3s3otVGrug%3D%3D, PID: 8505636
-
Shinotoh H, Inoue O, Hirayama K, Aotsuka A, Asahina M, Suhara T, Yamazaki T, Tateno Y (1993) Dopamine D1 receptors in Parkinson’s disease and striatonigral degeneration: a positron emission tomography study. J Neurol Neurosurg Psychiatry 56(5):467–472
-
(1993)
J Neurol Neurosurg Psychiatry
, vol.56
, Issue.5
, pp. 467-472
-
-
Shinotoh, H.1
Inoue, O.2
Hirayama, K.3
Aotsuka, A.4
Asahina, M.5
Suhara, T.6
Yamazaki, T.7
Tateno, Y.8
-
17
-
-
0030827709
-
In vivo studies on striatal dopamine D1 and D2 site binding in L-DOPA treated Parkinson’s disease patients with and without dyskinesias
-
COI: 1:CAS:528:DyaK2sXmtlOmtL8%3D, PID: 9305330
-
Turjanski N, Lees AJ, Brooks DJ (1997) In vivo studies on striatal dopamine D1 and D2 site binding in L-DOPA treated Parkinson’s disease patients with and without dyskinesias. Neurology 49:717–723
-
(1997)
Neurology
, vol.49
, pp. 717-723
-
-
Turjanski, N.1
Lees, A.J.2
Brooks, D.J.3
-
18
-
-
44649129998
-
Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA
-
COI: 1:CAS:528:DC%2BD1cXmvFSmt7o%3D, PID: 18504119
-
Cropley VL, Fujita M, Bara-Jimenez W, Brown AK, Zhang XY, Sangare J, Herscovitch P, Pike VW, Hallett M, Nathan PJ, Innis RB (2008) Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA. Psychiatry Res 163(2):171–182
-
(2008)
Psychiatry Res
, vol.163
, Issue.2
, pp. 171-182
-
-
Cropley, V.L.1
Fujita, M.2
Bara-Jimenez, W.3
Brown, A.K.4
Zhang, X.Y.5
Sangare, J.6
Herscovitch, P.7
Pike, V.W.8
Hallett, M.9
Nathan, P.J.10
Innis, R.B.11
-
19
-
-
0028149911
-
PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756
-
COI: 1:STN:280:DyaK2M%2FotFynsw%3D%3D, PID: 7989969
-
Laihinen AO, Rinne JO, Ruottinen HM, Någren KA, Lehikoinen PK, Oikonen VJ, Ruotsalainen UH, Rinne UK (1994) PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756. J Nucl Med 35(12):1916–1920
-
(1994)
J Nucl Med
, vol.35
, Issue.12
, pp. 1916-1920
-
-
Laihinen, A.O.1
Rinne, J.O.2
Ruottinen, H.M.3
Någren, K.A.4
Lehikoinen, P.K.5
Oikonen, V.J.6
Ruotsalainen, U.H.7
Rinne, U.K.8
-
20
-
-
34248211258
-
In vivo DA D(1) receptor selectivity of NNC 112 and SCH 23390
-
PID: 17473957
-
Ekelund J, Slifstein M, Narendran R, Guillin O, Belani H, Guo NN, Hwang Y, Hwang DR, Abi-Dargham A, Laruelle M (2007) In vivo DA D(1) receptor selectivity of NNC 112 and SCH 23390. Mol Imaging Biol 9(3):117–125
-
(2007)
Mol Imaging Biol
, vol.9
, Issue.3
, pp. 117-125
-
-
Ekelund, J.1
Slifstein, M.2
Narendran, R.3
Guillin, O.4
Belani, H.5
Guo, N.N.6
Hwang, Y.7
Hwang, D.R.8
Abi-Dargham, A.9
Laruelle, M.10
-
21
-
-
77952011907
-
Imaging cortical dopamine D1 receptors using [11C]NNC112 and ketanserin blockade of the 5-HT 2A receptors
-
COI: 1:CAS:528:DC%2BC3cXlsFWjs7o%3D, PID: 20029452
-
Catafau AM, Searle GE, Bullich S, Gunn RN, Rabiner EA, Herance R, Radua J, Farre M, Laruelle M (2010) Imaging cortical dopamine D1 receptors using [11C]NNC112 and ketanserin blockade of the 5-HT 2A receptors. J Cereb Blood Flow Metab 30(5):985–993
-
(2010)
J Cereb Blood Flow Metab
, vol.30
, Issue.5
, pp. 985-993
-
-
Catafau, A.M.1
Searle, G.E.2
Bullich, S.3
Gunn, R.N.4
Rabiner, E.A.5
Herance, R.6
Radua, J.7
Farre, M.8
Laruelle, M.9
-
22
-
-
0013277610
-
Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography
-
COI: 1:CAS:528:DyaL2MXkvVChsb4%3D, PID: 3873656
-
Farde L, Ehrin E, Eriksson L, Greitz T, Hall H, Hedström CG, Litton JE, Sedvall G (1985) Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc Natl Acad Sci USA 82(11):3863–3867
-
(1985)
Proc Natl Acad Sci USA
, vol.82
, Issue.11
, pp. 3863-3867
-
-
Farde, L.1
Ehrin, E.2
Eriksson, L.3
Greitz, T.4
Hall, H.5
Hedström, C.G.6
Litton, J.E.7
Sedvall, G.8
-
23
-
-
0025338472
-
Production of 3-N-[11C]methylspiperone with high specific activity and high radiochemical purity for PET studies: suppression of its radiolysis
-
COI: 1:CAS:528:DyaK3cXlt1yksLY%3D, PID: 1972936
-
Suzuki K, Inoue O, Tamate K, Mikado F (1990) Production of 3-N-[11C]methylspiperone with high specific activity and high radiochemical purity for PET studies: suppression of its radiolysis. Int J Rad Appl Instrum A 41(6):593–599
-
(1990)
Int J Rad Appl Instrum A
, vol.41
, Issue.6
, pp. 593-599
-
-
Suzuki, K.1
Inoue, O.2
Tamate, K.3
Mikado, F.4
-
24
-
-
0030593323
-
18F-desmethoxyfallypride: a fluorine-18 labeled radiotracer with properties similar to carbon-11 raclopride for PET imaging studies of dopamine D2 receptors
-
COI: 1:CAS:528:DyaK28Xks1altb0%3D, PID: 8761017
-
Mukherjee J, Yang ZY, Brown T, Roemer J, Cooper M (1996) 18F-desmethoxyfallypride: a fluorine-18 labeled radiotracer with properties similar to carbon-11 raclopride for PET imaging studies of dopamine D2 receptors. Life Sci 59(8):669–678
-
(1996)
Life Sci
, vol.59
, Issue.8
, pp. 669-678
-
-
Mukherjee, J.1
Yang, Z.Y.2
Brown, T.3
Roemer, J.4
Cooper, M.5
-
25
-
-
34548543972
-
In vitro affinities of various halogenated benzamide derivatives as potential radioligands for non-invasive quantification of D(2)-like dopamine receptors
-
COI: 1:CAS:528:DC%2BD2sXhtVCitr%2FM, PID: 17765546
-
Stark D, Piel M, Hübner H, Gmeiner P, Gründer G, Rösch F (2007) In vitro affinities of various halogenated benzamide derivatives as potential radioligands for non-invasive quantification of D(2)-like dopamine receptors. Bioorg Med Chem 15(21):6819–6829
-
(2007)
Bioorg Med Chem
, vol.15
, Issue.21
, pp. 6819-6829
-
-
Stark, D.1
Piel, M.2
Hübner, H.3
Gmeiner, P.4
Gründer, G.5
Rösch, F.6
-
26
-
-
0033623451
-
(-)-N-[(11)C]propyl-norapomorphine: a positron-labeled dopamine agonist for PET imaging of D(2) receptors
-
COI: 1:CAS:528:DC%2BD3cXosVWltbw%3D, PID: 11056366
-
Hwang DR, Kegeles LS, Laruelle M (2000) (-)-N-[(11)C]propyl-norapomorphine: a positron-labeled dopamine agonist for PET imaging of D(2) receptors. Nucl Med Biol 27(6):533–539
-
(2000)
Nucl Med Biol
, vol.27
, Issue.6
, pp. 533-539
-
-
Hwang, D.R.1
Kegeles, L.S.2
Laruelle, M.3
-
27
-
-
21044438149
-
A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey
-
COI: 1:CAS:528:DC%2BD2MXjvVKlu7Y%3D, PID: 15878504
-
Finnema SJ, Seneca N, Farde L, Shchukin E, Sóvágó J, Gulyás B, Wikström HV, Innis RB, Neumeyer JL, Halldin C (2005) A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey. Nucl Med Biol 32(4):353–360
-
(2005)
Nucl Med Biol
, vol.32
, Issue.4
, pp. 353-360
-
-
Finnema, S.J.1
Seneca, N.2
Farde, L.3
Shchukin, E.4
Sóvágó, J.5
Gulyás, B.6
Wikström, H.V.7
Innis, R.B.8
Neumeyer, J.L.9
Halldin, C.10
-
28
-
-
0034018859
-
Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review
-
COI: 1:CAS:528:DC%2BD3cXisVegurk%3D, PID: 10724107
-
Laruelle M (2000) Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20:423–451
-
(2000)
J Cereb Blood Flow Metab
, vol.20
, pp. 423-451
-
-
Laruelle, M.1
-
29
-
-
0032703626
-
Striatal D2 dopamine receptor status in Parkinson’s disease: an 18F DOPA and 11C-raclopride PET study
-
COI: 1:STN:280:DC%2BD3c%2FkvFektQ%3D%3D, PID: 10584682
-
Dentresangle C, Veyre L, le Bars Pierre C, Lavenne F, Pollak P, Guerin J, Froment JC, Brousolle E (1999) Striatal D2 dopamine receptor status in Parkinson’s disease: an 18F DOPA and 11C-raclopride PET study. Mov Disord 14(6):1025–1030
-
(1999)
Mov Disord
, vol.14
, Issue.6
, pp. 1025-1030
-
-
Dentresangle, C.1
Veyre, L.2
le Bars, P.C.3
Lavenne, F.4
Pollak, P.5
Guerin, J.6
Froment, J.C.7
Brousolle, E.8
-
30
-
-
0033957270
-
Upregulation of putaminal dopamine D2 receptors in early Parkinson’s disease: a comparative PET study with 11C-raclopride and 11C-methylspiperone
-
COI: 1:CAS:528:DC%2BD3cXotVSqtQ%3D%3D, PID: 10647606
-
Kaasinen V, Ruottinen HM, Nagren K, Lehikoinen P, Oikonen V, Rinne JO (2000) Upregulation of putaminal dopamine D2 receptors in early Parkinson’s disease: a comparative PET study with 11C-raclopride and 11C-methylspiperone. J Nucl Med 41:65–70
-
(2000)
J Nucl Med
, vol.41
, pp. 65-70
-
-
Kaasinen, V.1
Ruottinen, H.M.2
Nagren, K.3
Lehikoinen, P.4
Oikonen, V.5
Rinne, J.O.6
-
31
-
-
0027246667
-
Asymmetrical presynaptic and postsynaptic changes in the striatal dopamine projection in Dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status
-
PID: 8353712
-
Sawle GV, Playford ED, Brooks DJ, Quinn N, Frackowiak RS (1993) Asymmetrical presynaptic and postsynaptic changes in the striatal dopamine projection in Dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status. Brain 116:853–867
-
(1993)
Brain
, vol.116
, pp. 853-867
-
-
Sawle, G.V.1
Playford, E.D.2
Brooks, D.J.3
Quinn, N.4
Frackowiak, R.S.5
-
32
-
-
0031031846
-
Long-term changes of striatal dopamine D2 receptors in patients with Parkinson’s disease: a study with positron emission tomography and [11C]raclopride
-
COI: 1:STN:280:DyaK2s7ksVahtw%3D%3D, PID: 8990051
-
Antonini A, Schwarz J, Oertel WH, Pogarell O, Leenders KL (1997) Long-term changes of striatal dopamine D2 receptors in patients with Parkinson’s disease: a study with positron emission tomography and [11C]raclopride. Mov Disord 12(1):33–38
-
(1997)
Mov Disord
, vol.12
, Issue.1
, pp. 33-38
-
-
Antonini, A.1
Schwarz, J.2
Oertel, W.H.3
Pogarell, O.4
Leenders, K.L.5
-
33
-
-
0025612448
-
PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson’s disease
-
COI: 1:CAS:528:DyaK3MXnvFGqsA%3D%3D, PID: 1981915
-
Rinne JO, Laihinen A, Någren K, Bergman J, Solin O, Haaparanta M, Ruotsalainen U, Rinne UK (1990) PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson’s disease. J Neurosci Res 27(4):494–499
-
(1990)
J Neurosci Res
, vol.27
, Issue.4
, pp. 494-499
-
-
Rinne, J.O.1
Laihinen, A.2
Någren, K.3
Bergman, J.4
Solin, O.5
Haaparanta, M.6
Ruotsalainen, U.7
Rinne, U.K.8
-
34
-
-
0027176890
-
PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson’s disease
-
COI: 1:STN:280:DyaK3s3jtlKrug%3D%3D, PID: 8474478
-
Rinne JO, Laihinen A, Rinne UK, Någren K, Bergman J, Ruotsalainen U (1993) PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson’s disease. Mov Disord 8(2):134–138
-
(1993)
Mov Disord
, vol.8
, Issue.2
, pp. 134-138
-
-
Rinne, J.O.1
Laihinen, A.2
Rinne, U.K.3
Någren, K.4
Bergman, J.5
Ruotsalainen, U.6
-
35
-
-
0029126115
-
Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson’s disease: a PET study with [11C]raclopride
-
COI: 1:CAS:528:DyaK2MXptlWqtb0%3D, PID: 8543941
-
Rinne JO, Laihinen A, Ruottinen H, Ruotsalainen U, Någren K, Lehikoinen P, Oikonen V, Rinne UK (1995) Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson’s disease: a PET study with [11C]raclopride. J Neurol Sci 132(2):156–161
-
(1995)
J Neurol Sci
, vol.132
, Issue.2
, pp. 156-161
-
-
Rinne, J.O.1
Laihinen, A.2
Ruottinen, H.3
Ruotsalainen, U.4
Någren, K.5
Lehikoinen, P.6
Oikonen, V.7
Rinne, U.K.8
-
36
-
-
0030175258
-
Unilateral 6 hydroxy dopamine lesions in meso striatal dopamine neurons and their physiological sequelae
-
COI: 1:CAS:528:DyaK28XlvFKrt74%3D, PID: 8878304
-
Schwarting RK, Huston JP (1996) Unilateral 6 hydroxy dopamine lesions in meso striatal dopamine neurons and their physiological sequelae. Prog Neurobiol 49:215–266
-
(1996)
Prog Neurobiol
, vol.49
, pp. 215-266
-
-
Schwarting, R.K.1
Huston, J.P.2
-
37
-
-
0026612088
-
Striatal D2 receptor status in patients with Parkinson’s disease, striatonigral degeneration and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography
-
COI: 1:STN:280:DyaK383ks1ClsQ%3D%3D, PID: 1575457
-
Brooks DJ, Ibanez V, Saule GV, Playford ED, Quinn N, Mathias CJ, Lees AJ, Marsden CD, Bannister R, Frackowiak RS (1992) Striatal D2 receptor status in patients with Parkinson’s disease, striatonigral degeneration and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann Neurol 31:184–192
-
(1992)
Ann Neurol
, vol.31
, pp. 184-192
-
-
Brooks, D.J.1
Ibanez, V.2
Saule, G.V.3
Playford, E.D.4
Quinn, N.5
Mathias, C.J.6
Lees, A.J.7
Marsden, C.D.8
Bannister, R.9
Frackowiak, R.S.10
-
38
-
-
0028168112
-
[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson’s disease: influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors
-
COI: 1:STN:280:DyaK2czgvFyhsg%3D%3D, PID: 8035939
-
Antonini A, Schwarz J, Oertel WH, Beer HF, Madeja UD, Leenders KL (1994) [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson’s disease: influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors. Neurology 44(7):1325–1329
-
(1994)
Neurology
, vol.44
, Issue.7
, pp. 1325-1329
-
-
Antonini, A.1
Schwarz, J.2
Oertel, W.H.3
Beer, H.F.4
Madeja, U.D.5
Leenders, K.L.6
-
39
-
-
7744235165
-
Role of dopaminergic treatment in dopamine receptor downregulation in advanced Parkinson’s disease: a positron emission tomographic study
-
PID: 15534182
-
Thobois S, Vingerhoets F, Fraix V, Xie-Brustolin J, Mollion H, Costes N, Mertens P, Benebid AL, Pollak P, Broussolle E (2004) Role of dopaminergic treatment in dopamine receptor downregulation in advanced Parkinson’s disease: a positron emission tomographic study. Arch Neurol 61(11):1705–2179
-
(2004)
Arch Neurol
, vol.61
, Issue.11
, pp. 1705-2179
-
-
Thobois, S.1
Vingerhoets, F.2
Fraix, V.3
Xie-Brustolin, J.4
Mollion, H.5
Costes, N.6
Mertens, P.7
Benebid, A.L.8
Pollak, P.9
Broussolle, E.10
-
40
-
-
0024593812
-
Asymmetry of substantia nigra neuronal loss in Parkinson’s disease and its relevance to the mechanism of levodopa related motor fluctuations
-
COI: 1:STN:280:DyaL1M3hsFyktA%3D%3D, PID: 2709038
-
Kempster PA, Gibb WRG, Stern GM, Lees AJ (1989) Asymmetry of substantia nigra neuronal loss in Parkinson’s disease and its relevance to the mechanism of levodopa related motor fluctuations. J Neurol Neurosurg Psychiatry 52:72–76
-
(1989)
J Neurol Neurosurg Psychiatry
, vol.52
, pp. 72-76
-
-
Kempster, P.A.1
Gibb, W.R.G.2
Stern, G.M.3
Lees, A.J.4
-
41
-
-
0033955756
-
Evidence for impaired presynaptic dopamine function in Parkinsonian patients with motor fluctuations
-
de la Fuente Fernandez R, Pal PK, Vingerhoets FJG, Kishore A, Schulzer M, Mak EK, Ruth TJ, Snow BJ, Calne DB, Stoessl AJ (2000) Evidence for impaired presynaptic dopamine function in Parkinsonian patients with motor fluctuations. J Neural Trasm 107:49–57
-
(2000)
J Neural Trasm
, vol.107
, pp. 49-57
-
-
de la Fuente, F.R.1
Pal, P.K.2
Vingerhoets, F.J.G.3
Kishore, A.4
Schulzer, M.5
Mak, E.K.6
Ruth, T.J.7
Snow, B.J.8
Calne, D.B.9
Stoessl, A.J.10
-
42
-
-
0027415104
-
Dopamine D3 receptor mRNA and binding sites in human brain
-
COI: 1:CAS:528:DyaK3sXmtFOqtrs%3D, PID: 8097550
-
Landwehrmeyer B, Mengod G, Palacios JM (1993) Dopamine D3 receptor mRNA and binding sites in human brain. Brain Res Mol Brain Res 18:187–192
-
(1993)
Brain Res Mol Brain Res
, vol.18
, pp. 187-192
-
-
Landwehrmeyer, B.1
Mengod, G.2
Palacios, J.M.3
-
43
-
-
0028173396
-
Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain
-
COI: 1:CAS:528:DyaK2cXmvFems70%3D, PID: 7972046
-
Murray AM, Ryoo HL, Gurevich E, Joyce JN (1994) Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proc Natl Acad Sci USA 91:11271–11275
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 11271-11275
-
-
Murray, A.M.1
Ryoo, H.L.2
Gurevich, E.3
Joyce, J.N.4
-
44
-
-
20444379220
-
Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6, 10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9 -ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography
-
COI: 1:CAS:528:DC%2BD2MXkt1Wru78%3D, PID: 15943487
-
Wilson AA, McCormick P, Kapur S, Willeit M, Garcia A, Hussey D, Houle S, Seeman P, Ginovart N (2005) Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6, 10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9 -ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography. J Med Chem 48:4153
-
(2005)
J Med Chem
, vol.48
, pp. 4153
-
-
Wilson, A.A.1
McCormick, P.2
Kapur, S.3
Willeit, M.4
Garcia, A.5
Hussey, D.6
Houle, S.7
Seeman, P.8
Ginovart, N.9
-
45
-
-
0027185464
-
Dopamine receptors labelled by PHNO
-
COI: 1:CAS:528:DyaK2cXht1GjtLs%3D, PID: 7902615
-
Seeman P, Ulpian C, Larsen RD, Anderson PS (1993) Dopamine receptors labelled by PHNO. Synapse 14:254–262
-
(1993)
Synapse
, vol.14
, pp. 254-262
-
-
Seeman, P.1
Ulpian, C.2
Larsen, R.D.3
Anderson, P.S.4
-
46
-
-
33344454906
-
High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO
-
COI: 1:CAS:528:DC%2BD28XhvVehurY%3D, PID: 16373068
-
Willeit M, Ginovart N, Kapur S, Houle S, Hussey D, Seeman P, Wilson AA (2006) High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO. Biol Psychiatry 59:389–394
-
(2006)
Biol Psychiatry
, vol.59
, pp. 389-394
-
-
Willeit, M.1
Ginovart, N.2
Kapur, S.3
Houle, S.4
Hussey, D.5
Seeman, P.6
Wilson, A.A.7
-
47
-
-
42049106825
-
Brain region binding of the D(2/3) agonist [(11)C]-(+)-PHNO and the D(2/3) antagonist [(11)C]raclopride in healthy humans
-
PID: 17497628
-
Graff-Guerrero A, Willeit M, Ginovart N, Mamo D, Mizrahi R, Rusjan P, Vitcu I, Seeman P, Wilson AA, Kapur S (2008) Brain region binding of the D(2/3) agonist [(11)C]-(+)-PHNO and the D(2/3) antagonist [(11)C]raclopride in healthy humans. Hum Brain Mapp 29:400–410
-
(2008)
Hum Brain Mapp
, vol.29
, pp. 400-410
-
-
Graff-Guerrero, A.1
Willeit, M.2
Ginovart, N.3
Mamo, D.4
Mizrahi, R.5
Rusjan, P.6
Vitcu, I.7
Seeman, P.8
Wilson, A.A.9
Kapur, S.10
-
48
-
-
68049134258
-
In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: studies in non-human primates and transgenic mice
-
COI: 1:CAS:528:DC%2BD1MXovV2ltL8%3D, PID: 19489048
-
Rabiner EA, Slifstein M, Nobrega J, Plisson C, Huiban M, Raymond R, Diwan M, Wilson AA, McCormick P, Gentile G, Gunn RN, Laruelle MA (2009) In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: studies in non-human primates and transgenic mice. Synapse 63(9):782–793
-
(2009)
Synapse
, vol.63
, Issue.9
, pp. 782-793
-
-
Rabiner, E.A.1
Slifstein, M.2
Nobrega, J.3
Plisson, C.4
Huiban, M.5
Raymond, R.6
Diwan, M.7
Wilson, A.A.8
McCormick, P.9
Gentile, G.10
Gunn, R.N.11
Laruelle, M.A.12
-
49
-
-
66549099622
-
Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson’s disease
-
PID: 19153147
-
Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J, Hornykiewicz O, Furukawa Y, Wilson AA, Kapur S, Kish SJ (2009) Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson’s disease. Brain 132(Pt 5):1366–1375
-
(2009)
Brain
, vol.132
, pp. 1366-1375
-
-
Boileau, I.1
Guttman, M.2
Rusjan, P.3
Adams, J.R.4
Houle, S.5
Tong, J.6
Hornykiewicz, O.7
Furukawa, Y.8
Wilson, A.A.9
Kapur, S.10
Kish, S.J.11
-
50
-
-
18244412384
-
Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals
-
COI: 1:CAS:528:DyaK1MXhsFSmsA%3D%3D, PID: 9851438
-
Hattori N, Kitada T, Matsumine H, Asakawa S, Yamamura Y, Yoshino H, Kobayashi T, Yokochi M, Wang M, Yoritaka A, Kondo T, Kuzuhara S, Nakamura S, Shimizu N, Mizuno Y (1998) Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals. Ann Neurol 44:935–941
-
(1998)
Ann Neurol
, vol.44
, pp. 935-941
-
-
Hattori, N.1
Kitada, T.2
Matsumine, H.3
Asakawa, S.4
Yamamura, Y.5
Yoshino, H.6
Kobayashi, T.7
Yokochi, M.8
Wang, M.9
Yoritaka, A.10
Kondo, T.11
Kuzuhara, S.12
Nakamura, S.13
Shimizu, N.14
Mizuno, Y.15
-
51
-
-
0345490853
-
A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson’s Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson’s disease
-
COI: 1:CAS:528:DyaK1MXitlGgu7Y%3D, PID: 10072423
-
Abbas N, Lücking CB, Ricard S, Dürr A, Bonifati V, De Michele G, Bouley S, Vaughan JR, Gasser T, Marconi R, Broussolle E, Brefel-Courbon C, Harhangi BS, Oostra BA, Fabrizio E, Böhme GA, Pradier L, Wood NW, Filla A, Meco G, Denefle P, Agid Y, Brice A (1999) A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson’s Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson’s disease. Hum Mol Genet 8(4):567–574
-
(1999)
Hum Mol Genet
, vol.8
, Issue.4
, pp. 567-574
-
-
Abbas, N.1
Lücking, C.B.2
Ricard, S.3
Dürr, A.4
Bonifati, V.5
De Michele, G.6
Bouley, S.7
Vaughan, J.R.8
Gasser, T.9
Marconi, R.10
Broussolle, E.11
Brefel-Courbon, C.12
Harhangi, B.S.13
Oostra, B.A.14
Fabrizio, E.15
Böhme, G.A.16
Pradier, L.17
Wood, N.W.18
Filla, A.19
Meco, G.20
Denefle, P.21
Agid, Y.22
Brice, A.23
more..
-
52
-
-
0033933048
-
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
-
COI: 1:STN:280:DC%2BD3czptF2nsw%3D%3D, PID: 10888878
-
Shimura H, Hattori N, Si Kubo, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, Suzuki T (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 25(3):302–305
-
(2000)
Nat Genet
, vol.25
, Issue.3
, pp. 302-305
-
-
Shimura, H.1
Hattori, N.2
Si, K.3
Mizuno, Y.4
Asakawa, S.5
Minoshima, S.6
Shimizu, N.7
Iwai, K.8
Chiba, T.9
Tanaka, K.10
Suzuki, T.11
-
53
-
-
8844233579
-
Mutations in LRRK2 cause autosomal dominant parkinsonism with pleomorphic pathology
-
COI: 1:CAS:528:DC%2BD2cXhtVKhurjL, PID: 15541309
-
Zimprich A, Biskup S, Leitner P, Lichner M, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti R, Calne D (2004) Mutations in LRRK2 cause autosomal dominant parkinsonism with pleomorphic pathology. Neuron 44(4):601–607
-
(2004)
Neuron
, vol.44
, Issue.4
, pp. 601-607
-
-
Zimprich, A.1
Biskup, S.2
Leitner, P.3
Lichner, M.4
Farrer, M.5
Lincoln, S.6
Kachergus, J.7
Hulihan, M.8
Uitti, R.9
Calne, D.10
-
54
-
-
2942534518
-
Striatal and cortical pre and postsynaptic dopaminergic dysfunction in sporadic parkin linked parkinsonism
-
PID: 15090472
-
Scherfler C, Khan NL, Pavese N, Eunson L, Graham E, Lees AJ, Quinn NP, Wood NW, Brooks DJ, Piccini P (2004) Striatal and cortical pre and postsynaptic dopaminergic dysfunction in sporadic parkin linked parkinsonism. Brain 127(6):1332–1342
-
(2004)
Brain
, vol.127
, Issue.6
, pp. 1332-1342
-
-
Scherfler, C.1
Khan, N.L.2
Pavese, N.3
Eunson, L.4
Graham, E.5
Lees, A.J.6
Quinn, N.P.7
Wood, N.W.8
Brooks, D.J.9
Piccini, P.10
-
55
-
-
33745827777
-
Upregulation of dopamine D2 receptors in dopaminergic drug naïve patients with parkin gene mutations
-
PID: 16511856
-
Scherfler C, Khan NL, Pavese N, Lees AJ, Quinn NP, Brooks DJ, Piccini P (2006) Upregulation of dopamine D2 receptors in dopaminergic drug naïve patients with parkin gene mutations. Mov Disord 21(6):783–788
-
(2006)
Mov Disord
, vol.21
, Issue.6
, pp. 783-788
-
-
Scherfler, C.1
Khan, N.L.2
Pavese, N.3
Lees, A.J.4
Quinn, N.P.5
Brooks, D.J.6
Piccini, P.7
-
56
-
-
0030612619
-
Kinetic modeling of [11C]raclopride: combined PET-microdialysis studies
-
COI: 1:CAS:528:DyaK2sXmsVagtb8%3D
-
Endres CJ, Kolachana BS, Saunders RC, Su T, Weinberger D, Breier A, Eckelman WC, Carson RE (1997) Kinetic modeling of [11C]raclopride: combined PET-microdialysis studies. Cereb Blood Flow Metab 17(9):932–942
-
(1997)
Cereb Blood Flow Metab
, vol.17
, Issue.9
, pp. 932-942
-
-
Endres, C.J.1
Kolachana, B.S.2
Saunders, R.C.3
Su, T.4
Weinberger, D.5
Breier, A.6
Eckelman, W.C.7
Carson, R.E.8
-
57
-
-
0033381760
-
Recent advances in atypical parkinsonian disorders
-
COI: 1:STN:280:DC%2BD3c%2Fit1Omuw%3D%3D, PID: 10555833
-
Litvan I (1999) Recent advances in atypical parkinsonian disorders. Curr Opin Neurol 12(4):441–446
-
(1999)
Curr Opin Neurol
, vol.12
, Issue.4
, pp. 441-446
-
-
Litvan, I.1
-
58
-
-
3943053477
-
The dopamine D2 receptor ligand 18F-desmethoxyfallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism
-
COI: 1:CAS:528:DC%2BD2cXmtFWks7s%3D, PID: 15042325
-
Schreckenberger M, Hägele S, Siessmeier T, Buchholz HG, Armbrust-Henrich H, Rösch F, Gründer G, Bartenstein P, Vogt T (2004) The dopamine D2 receptor ligand 18F-desmethoxyfallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism. Eur J Nucl Med Mol Imaging 31(8):1128–1135
-
(2004)
Eur J Nucl Med Mol Imaging
, vol.31
, Issue.8
, pp. 1128-1135
-
-
Schreckenberger, M.1
Hägele, S.2
Siessmeier, T.3
Buchholz, H.G.4
Armbrust-Henrich, H.5
Rösch, F.6
Gründer, G.7
Bartenstein, P.8
Vogt, T.9
-
59
-
-
77950961958
-
The value of the dopamine D2/3 receptor ligand 18F-desmethoxyfallypride for the differentiation of idiopathic and nonidiopathic parkinsonian syndromes
-
PID: 20237026
-
la Fougère C, Pöpperl G, Levin J, Wängler B, Böning G, Uebleis C, Cumming P, Bartenstein P, Bötzel K, Tatsch K (2010) The value of the dopamine D2/3 receptor ligand 18F-desmethoxyfallypride for the differentiation of idiopathic and nonidiopathic parkinsonian syndromes. J Nucl Med 51(4):581–587
-
(2010)
J Nucl Med
, vol.51
, Issue.4
, pp. 581-587
-
-
la Fougère, C.1
Pöpperl, G.2
Levin, J.3
Wängler, B.4
Böning, G.5
Uebleis, C.6
Cumming, P.7
Bartenstein, P.8
Bötzel, K.9
Tatsch, K.10
-
60
-
-
84867507249
-
123I]IBZM-SPECT for the differential diagnosis of parkinsonism
-
COI: 1:CAS:528:DC%2BC38XhsVWmtrvF, PID: 22914831
-
123I]IBZM-SPECT for the differential diagnosis of parkinsonism. Neurology 79(13):1314–1322
-
(2012)
Neurology
, vol.79
, Issue.13
, pp. 1314-1322
-
-
Hellwig, S.1
Amtage, F.2
Kreft, A.3
Buchert, R.4
Winz, O.H.5
Vach, W.6
Spehl, T.S.7
Rijntjes, M.8
Hellwig, B.9
Weiller, C.10
Winkler, C.11
Weber, W.A.12
Tüscher, O.13
Meyer, P.T.14
-
61
-
-
54049120959
-
Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson’s disease: an in vivo 11C-raclopride PET study
-
COI: 1:CAS:528:DC%2BD1cXht12ns7%2FL, PID: 18723016
-
Politis M, Piccini P, Pavese N, Koh SB, Brooks DJ (2008) Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson’s disease: an in vivo 11C-raclopride PET study. Exp Neurol 214:112–116
-
(2008)
Exp Neurol
, vol.214
, pp. 112-116
-
-
Politis, M.1
Piccini, P.2
Pavese, N.3
Koh, S.B.4
Brooks, D.J.5
-
62
-
-
0029067190
-
Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors
-
COI: 1:CAS:528:DyaK2MXntFSjur8%3D, PID: 7790956
-
Halldin C, Farde L, Högberg T, Mohell N, Hall H, Suhara T, Karlsson P, Nakashima Y, Swahn CG (1995) Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors. J Nucl Med 36(7):1275–1281
-
(1995)
J Nucl Med
, vol.36
, Issue.7
, pp. 1275-1281
-
-
Halldin, C.1
Farde, L.2
Högberg, T.3
Mohell, N.4
Hall, H.5
Suhara, T.6
Karlsson, P.7
Nakashima, Y.8
Swahn, C.G.9
-
63
-
-
17644438752
-
Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson’s disease
-
COI: 1:CAS:528:DC%2BD3cXivFOitbw%3D, PID: 10751262
-
Kaasinen V, Någren K, Hietala J, Oikonen V, Vilkman H, Farde L, Halldin C, Rinne JO (2000) Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson’s disease. Neurology 54(7):1482–1487
-
(2000)
Neurology
, vol.54
, Issue.7
, pp. 1482-1487
-
-
Kaasinen, V.1
Någren, K.2
Hietala, J.3
Oikonen, V.4
Vilkman, H.5
Farde, L.6
Halldin, C.7
Rinne, J.O.8
-
64
-
-
0038521243
-
Extrastriatal dopamine D(2) receptors in Parkinson’s disease: a longitudinal study
-
COI: 1:CAS:528:DC%2BD3sXntlKhs78%3D, PID: 12768355
-
Kaasinen V, Aalto S, Nagren K, Hietala J, Sonninen P, Rinne JO (2003) Extrastriatal dopamine D(2) receptors in Parkinson’s disease: a longitudinal study. J Neural Transm 110(6):591–601
-
(2003)
J Neural Transm
, vol.110
, Issue.6
, pp. 591-601
-
-
Kaasinen, V.1
Aalto, S.2
Nagren, K.3
Hietala, J.4
Sonninen, P.5
Rinne, J.O.6
-
65
-
-
0344430080
-
Raclopride studies of dopamine release: dependence on presynaptic integrity
-
COI: 1:CAS:528:DC%2BD3sXpt1Wiu7k%3D, PID: 14643086
-
Doudet DJ, Holden JE (2003) Raclopride studies of dopamine release: dependence on presynaptic integrity. Biol Psychiatry 54:1193–1199
-
(2003)
Biol Psychiatry
, vol.54
, pp. 1193-1199
-
-
Doudet, D.J.1
Holden, J.E.2
-
66
-
-
12644293806
-
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method
-
COI: 1:CAS:528:DyaK2sXhvF2ksLg%3D, PID: 9122236
-
Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D (1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 94(6):2569–2574
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, Issue.6
, pp. 2569-2574
-
-
Breier, A.1
Su, T.P.2
Saunders, R.3
Carson, R.E.4
Kolachana, B.S.5
de Bartolomeis, A.6
Weinberger, D.R.7
Weisenfeld, N.8
Malhotra, A.K.9
Eckelman, W.C.10
Pickar, D.11
-
67
-
-
0037312540
-
Dopamine release during sequential finger movements in health and Parkinson’s disease: a PET study
-
PID: 12538400
-
Goerendt IK, Messa C, Lawrence AD, Grasby PM, Piccini P, Brooks DJ (2003) Dopamine release during sequential finger movements in health and Parkinson’s disease: a PET study. Brain 126:312–325
-
(2003)
Brain
, vol.126
, pp. 312-325
-
-
Goerendt, I.K.1
Messa, C.2
Lawrence, A.D.3
Grasby, P.M.4
Piccini, P.5
Brooks, D.J.6
-
68
-
-
0029904201
-
Levodopa induced changes in synaptic dopamine in patients with Parkinson’s disease as measured by 11C-raclopride displacement and PET
-
COI: 1:STN:280:DyaK283ht1GrtQ%3D%3D, PID: 8628494
-
Tedroff J, Pederson M, Aquilonius SM, Hartvig P, Jacobsson G, Langstrom B (1996) Levodopa induced changes in synaptic dopamine in patients with Parkinson’s disease as measured by 11C-raclopride displacement and PET. Neurology 46:1430–1436
-
(1996)
Neurology
, vol.46
, pp. 1430-1436
-
-
Tedroff, J.1
Pederson, M.2
Aquilonius, S.M.3
Hartvig, P.4
Jacobsson, G.5
Langstrom, B.6
-
69
-
-
0038523950
-
Endogenous dopamine release after pharmacological challenges in Parkinson’s disease
-
COI: 1:CAS:528:DC%2BD3sXktVSnt78%3D, PID: 12730999
-
Piccini P, Pavese N, Brooks DJ (2003) Endogenous dopamine release after pharmacological challenges in Parkinson’s disease. Ann Neurol 53:647–653
-
(2003)
Ann Neurol
, vol.53
, pp. 647-653
-
-
Piccini, P.1
Pavese, N.2
Brooks, D.J.3
-
70
-
-
33746895102
-
Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson’s disease patients: PET studies
-
PID: 16570297
-
Koochesfahani KM, de la Fuerte-Fernandes R, Sossi V, Schulzer M, Lakshmi N, Yatham LN, Ruth TJ, Blinder S, Stoessl AJ (2006) Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson’s disease patients: PET studies. Mov Disord 21(7):970–975
-
(2006)
Mov Disord
, vol.21
, Issue.7
, pp. 970-975
-
-
Koochesfahani, K.M.1
de la Fuerte-Fernandes, R.2
Sossi, V.3
Schulzer, M.4
Lakshmi, N.5
Yatham, L.N.6
Ruth, T.J.7
Blinder, S.8
Stoessl, A.J.9
-
71
-
-
44949221767
-
Cognitive deficits and striatal-frontal dopamine release in Parkinson’s disease
-
PID: 18362097
-
Sawamoto N, Piccini P, Hotten G, Pavese N, Thielemans K, Brooks DJ (2008) Cognitive deficits and striatal-frontal dopamine release in Parkinson’s disease. Brain 131:1294–1302
-
(2008)
Brain
, vol.131
, pp. 1294-1302
-
-
Sawamoto, N.1
Piccini, P.2
Hotten, G.3
Pavese, N.4
Thielemans, K.5
Brooks, D.J.6
-
72
-
-
0035092779
-
Biochemical variations in the synaptic levels of dopamine precede motor fluctuations in Parkinson’s disease: PET evidence of increased dopamine turnover
-
PID: 11261503
-
de la Fuente-Fernandez R, Lu JQ, Sossi V, Jivan S, Schulzer M, Holden JE, Lee CS, Ruth TJ, Calne DB, Stoessl AJ (2001) Biochemical variations in the synaptic levels of dopamine precede motor fluctuations in Parkinson’s disease: PET evidence of increased dopamine turnover. Ann Neurol 49:298–303
-
(2001)
Ann Neurol
, vol.49
, pp. 298-303
-
-
de la Fuente-Fernandez, R.1
Lu, J.Q.2
Sossi, V.3
Jivan, S.4
Schulzer, M.5
Holden, J.E.6
Lee, C.S.7
Ruth, T.J.8
Calne, D.B.9
Stoessl, A.J.10
-
73
-
-
0034784464
-
Apomorphine-induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition
-
de la Fuente-Fernández R, Lim AS, Sossi V, Holden JE, Calne DB, Ruth TJ, Stoessl AJ (2001) Apomorphine-induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition. J Cereb Blood Flow Metab 21:1151–1159
-
(2001)
J Cereb Blood Flow Metab
, vol.21
, pp. 1151-1159
-
-
de la Fuente-Fernández, R.1
Lim, A.S.2
Sossi, V.3
Holden, J.E.4
Calne, D.B.5
Ruth, T.J.6
Stoessl, A.J.7
-
74
-
-
10344236071
-
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson’s disease: implications for dyskinesias
-
PID: 15329355
-
de la Fuente-Fernandez R, Sossi V, Huang Z, Furtado S, Lu QR, Calne DB, Ruth TJ, Stoessl AJ (2004) Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson’s disease: implications for dyskinesias. Brain 127:2747–2754
-
(2004)
Brain
, vol.127
, pp. 2747-2754
-
-
de la Fuente-Fernandez, R.1
Sossi, V.2
Huang, Z.3
Furtado, S.4
Lu, Q.R.5
Calne, D.B.6
Ruth, T.J.7
Stoessl, A.J.8
-
75
-
-
33750975077
-
Clinical correlates of levodopa induced dopamine release in Parkinson’s disease: a PET study
-
COI: 1:CAS:528:DC%2BD28XhtFChsLnO, PID: 17101892
-
Pavese N, Evans AH, Tai YF, Hotton G, Brooks DJ, Lees AJ, Piccini P (2006) Clinical correlates of levodopa induced dopamine release in Parkinson’s disease: a PET study. Neurology 67:1612–1617
-
(2006)
Neurology
, vol.67
, pp. 1612-1617
-
-
Pavese, N.1
Evans, A.H.2
Tai, Y.F.3
Hotton, G.4
Brooks, D.J.5
Lees, A.J.6
Piccini, P.7
-
76
-
-
0033491121
-
Dopamine release from nigral transplants visualised in vivo in a Parkinson’s patient
-
Piccini P, Brooks DJ, Bjorklund A, Gunn RN, Grasby PM, Rimoldi O, Brundin P, Hagell P, Rehncrona S, Widner H, Lindvall O (1999) Dopamine release from nigral transplants visualised in vivo in a Parkinson’s patient. Nat Neurosci 2(12):1047–1048
-
(1999)
Nat Neurosci
, vol.2
, Issue.12
, pp. 1047-1048
-
-
Piccini, P.1
Brooks, D.J.2
Bjorklund, A.3
Gunn, R.N.4
Grasby, P.M.5
Rimoldi, O.6
Brundin, P.7
Hagell, P.8
Rehncrona, S.9
Widner, H.10
Lindvall, O.11
-
77
-
-
28544441892
-
Factors affecting the clinical outcome after neural transplantation in Parkinson’s disease
-
PID: 16246865
-
Piccini P, Pavese N, Hagell P, Reiner J, Bjorklund A, Oertel WH, Quinn NP, Brooks DJ, Lindvall O (2005) Factors affecting the clinical outcome after neural transplantation in Parkinson’s disease. Brain 128(12):2977–2986
-
(2005)
Brain
, vol.128
, Issue.12
, pp. 2977-2986
-
-
Piccini, P.1
Pavese, N.2
Hagell, P.3
Reiner, J.4
Bjorklund, A.5
Oertel, W.H.6
Quinn, N.P.7
Brooks, D.J.8
Lindvall, O.9
-
78
-
-
77955617871
-
Serotonergic neurons mediate dyskinesia side effects in Parkinson’s patients with neural transplants
-
Politis M, Wu K, Loane C, Quinn NP, Brooks DJ, Rehncrona S, Bjorklund A, Lindvall O, Piccini P (2010) Serotonergic neurons mediate dyskinesia side effects in Parkinson’s patients with neural transplants. Sci Transl Med 2(38):38–46
-
(2010)
Sci Transl Med
, vol.2
, Issue.38
, pp. 38-46
-
-
Politis, M.1
Wu, K.2
Loane, C.3
Quinn, N.P.4
Brooks, D.J.5
Rehncrona, S.6
Bjorklund, A.7
Lindvall, O.8
Piccini, P.9
-
79
-
-
80052971467
-
Graft-induced dyskinesias in Parkinson’s disease: high striatal serotonin/dopamine transporter ratio
-
PID: 21611977
-
Politis M, Oertel WH, Wu K, Quinn NP, Pogarell O, Brooks DJ, Bjorklund A, Lindvall O, Piccini P (2011) Graft-induced dyskinesias in Parkinson’s disease: high striatal serotonin/dopamine transporter ratio. Mov Disord 26(11):1997–2003
-
(2011)
Mov Disord
, vol.26
, Issue.11
, pp. 1997-2003
-
-
Politis, M.1
Oertel, W.H.2
Wu, K.3
Quinn, N.P.4
Pogarell, O.5
Brooks, D.J.6
Bjorklund, A.7
Lindvall, O.8
Piccini, P.9
-
80
-
-
84859496019
-
Serotonin neuron loss and nonmotor symptoms continue in Parkinson’s patients treated with dopamine grafts
-
Politis M, Wu K, Loane C, Quinn NP, Brooks DJ, Oertel WH, Björklund A, Lindvall O, Piccini P (2012) Serotonin neuron loss and nonmotor symptoms continue in Parkinson’s patients treated with dopamine grafts. Sci Transl Med 4(128):128–141
-
(2012)
Sci Transl Med
, vol.4
, Issue.128
, pp. 128-141
-
-
Politis, M.1
Wu, K.2
Loane, C.3
Quinn, N.P.4
Brooks, D.J.5
Oertel, W.H.6
Björklund, A.7
Lindvall, O.8
Piccini, P.9
-
81
-
-
0036830588
-
Dyskinesia after fetal cell transplantation for Parkinsonism: a PET study
-
PID: 12402261
-
Ma Y, Feigin A, Dhawan V, Fukuda M, Shi Q, Greene P, Breeze R, Fahn S, Freed C, Eidelberg D (2002) Dyskinesia after fetal cell transplantation for Parkinsonism: a PET study. Ann Neurol 52:628–634
-
(2002)
Ann Neurol
, vol.52
, pp. 628-634
-
-
Ma, Y.1
Feigin, A.2
Dhawan, V.3
Fukuda, M.4
Shi, Q.5
Greene, P.6
Breeze, R.7
Fahn, S.8
Freed, C.9
Eidelberg, D.10
-
82
-
-
0036307190
-
Dyskinesias following neural transplantation in Parkinson’s disease
-
COI: 1:CAS:528:DC%2BD38Xkslyisr4%3D, PID: 12042822
-
Hagell P, Piccini P, Björklund A, Brundin P, Rehncrona S, Widner H, Crabb L, Pavese N, Oertel WH, Quinn N, Brooks DJ, Lindvall O (2002) Dyskinesias following neural transplantation in Parkinson’s disease. Nat Neurosci 5(7):627–628
-
(2002)
Nat Neurosci
, vol.5
, Issue.7
, pp. 627-628
-
-
Hagell, P.1
Piccini, P.2
Björklund, A.3
Brundin, P.4
Rehncrona, S.5
Widner, H.6
Crabb, L.7
Pavese, N.8
Oertel, W.H.9
Quinn, N.10
Brooks, D.J.11
Lindvall, O.12
-
83
-
-
0033809201
-
Pathologic gambling in Parkinson’s disease: a behavioral manifestation of pharmacologic treatment?
-
COI: 1:STN:280:DC%2BD3cvlt1yisw%3D%3D, PID: 11009192
-
Molina JA, Sáinz-Artiga MJ, Fraile A, Jiménez-Jiménez FJ, Villanueva C, Ortí-Pareja M, Bermejo F (2000) Pathologic gambling in Parkinson’s disease: a behavioral manifestation of pharmacologic treatment? Mov Disord 15(5):869–872
-
(2000)
Mov Disord
, vol.15
, Issue.5
, pp. 869-872
-
-
Molina, J.A.1
Sáinz-Artiga, M.J.2
Fraile, A.3
Jiménez-Jiménez, F.J.4
Villanueva, C.5
Ortí-Pareja, M.6
Bermejo, F.7
-
84
-
-
72049085005
-
Impulsive choice and response in dopamine agonist-related impulse control behaviours
-
COI: 1:CAS:528:DC%2BD1MXhsVOgtLbI, PID: 19838863
-
Voon V, Reynolds B, Brezing C, Galleo C, Skaljic M, Ekanayake V, Fernandez H, Potenza MN, Dolan RJ, Hallett M (2010) Impulsive choice and response in dopamine agonist-related impulse control behaviours. Psychopharmacology 207(4):645–659
-
(2010)
Psychopharmacology
, vol.207
, Issue.4
, pp. 645-659
-
-
Voon, V.1
Reynolds, B.2
Brezing, C.3
Galleo, C.4
Skaljic, M.5
Ekanayake, V.6
Fernandez, H.7
Potenza, M.N.8
Dolan, R.J.9
Hallett, M.10
-
85
-
-
0026580695
-
The DSM-III-R impulse control disorders not elsewhere classified: clinical characteristics and relationships to other psychiatric disorders
-
COI: 1:STN:280:DyaK387mtV2ltw%3D%3D, PID: 1536268
-
McElroy SL, Hudson JI, Pope HJ, Keck PE, Aizley HG (1992) The DSM-III-R impulse control disorders not elsewhere classified: clinical characteristics and relationships to other psychiatric disorders. Am J Psychiatry 149:318–327
-
(1992)
Am J Psychiatry
, vol.149
, pp. 318-327
-
-
McElroy, S.L.1
Hudson, J.I.2
Pope, H.J.3
Keck, P.E.4
Aizley, H.G.5
-
86
-
-
0034055187
-
Hedonistic homeostasis dysregulation in patients with Parkinson’s disease on dopamine replacement therapies
-
COI: 1:STN:280:DC%2BD3c7ptlOisQ%3D%3D, PID: 10727476
-
Giovannoni G, O’Sullivan JD, Turner K, Manson AJ, Lees AJ (2000) Hedonistic homeostasis dysregulation in patients with Parkinson’s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423–428
-
(2000)
J Neurol Neurosurg Psychiatry
, vol.68
, pp. 423-428
-
-
Giovannoni, G.1
O’Sullivan, J.D.2
Turner, K.3
Manson, A.J.4
Lees, A.J.5
-
87
-
-
33646358930
-
Compulsive drug use linked to sensitized ventral striatal dopamine transmission
-
COI: 1:CAS:528:DC%2BD28XkvFKhsbs%3D, PID: 16557571
-
Evans AH, Pavese N, Lawrence AD, Tai FY, Appel S, Doder M, Brooks DJ, Lees AJ, Piccini P (2006) Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 59:852–858
-
(2006)
Ann Neurol
, vol.59
, pp. 852-858
-
-
Evans, A.H.1
Pavese, N.2
Lawrence, A.D.3
Tai, F.Y.4
Appel, S.5
Doder, M.6
Brooks, D.J.7
Lees, A.J.8
Piccini, P.9
-
88
-
-
66549083459
-
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a 11C-raclopride PET study
-
COI: 1:STN:280:DC%2BD1MzisFWgsg%3D%3D, PID: 19346328
-
Steeves TDL, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, van Elmeren T, Rusjan P, Houle S, Strafella AP (2009) Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a 11C-raclopride PET study. Brain 132:1376–1385
-
(2009)
Brain
, vol.132
, pp. 1376-1385
-
-
Steeves, T.D.L.1
Miyasaki, J.2
Zurowski, M.3
Lang, A.E.4
Pellecchia, G.5
van Elmeren, T.6
Rusjan, P.7
Houle, S.8
Strafella, A.P.9
-
89
-
-
84880174056
-
Dopaminergic and clinical correlates of pathological gambling in Parkinson’s disease: a case report
-
PID: 23908610
-
Callesen MB, Hansen KV, Gjedde A, Linnet J, Møller A (2013) Dopaminergic and clinical correlates of pathological gambling in Parkinson’s disease: a case report. Front Behav Neurosci 7:95
-
(2013)
Front Behav Neurosci
, vol.7
, pp. 95
-
-
Callesen, M.B.1
Hansen, K.V.2
Gjedde, A.3
Linnet, J.4
Møller, A.5
-
90
-
-
79953658757
-
Cue-induced striatal dopamine release in Parkinson’s disease-associated impulsive-compulsive behaviours
-
PID: 21349901
-
O’Sullivan SS, Wu K, Politis M, Lawrence AD, Evans AH, Bose SK, Djamshidian A, Lees AJ, Piccini P (2011) Cue-induced striatal dopamine release in Parkinson’s disease-associated impulsive-compulsive behaviours. Brain 134(Pt 4):969–978
-
(2011)
Brain
, vol.134
, pp. 969-978
-
-
O’Sullivan, S.S.1
Wu, K.2
Politis, M.3
Lawrence, A.D.4
Evans, A.H.5
Bose, S.K.6
Djamshidian, A.7
Lees, A.J.8
Piccini, P.9
-
91
-
-
84874341545
-
Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson’s disease
-
PID: 23378222
-
Politis M, Loane C, Wu K, O’Sullivan SS, Woodhead Z, Kiferle L, Lawrence AD, Lees AJ, Piccini P (2013) Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson’s disease. Brain 136(Pt 2):400–411
-
(2013)
Brain
, vol.136
, pp. 400-411
-
-
Politis, M.1
Loane, C.2
Wu, K.3
O’Sullivan, S.S.4
Woodhead, Z.5
Kiferle, L.6
Lawrence, A.D.7
Lees, A.J.8
Piccini, P.9
-
92
-
-
84865300674
-
Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson’s patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study
-
COI: 1:CAS:528:DC%2BC38XhsVCjurfI, PID: 22766031
-
Ray NJ, Miyasaki JM, Zurowski M, Ko JH, Cho SS, Pellecchia G, Antonelli F, Houle S, Lang AE, Strafella AP (2012) Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson’s patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study. Neurobiol Dis 48(3):519–525
-
(2012)
Neurobiol Dis
, vol.48
, Issue.3
, pp. 519-525
-
-
Ray, N.J.1
Miyasaki, J.M.2
Zurowski, M.3
Ko, J.H.4
Cho, S.S.5
Pellecchia, G.6
Antonelli, F.7
Houle, S.8
Lang, A.E.9
Strafella, A.P.10
-
93
-
-
47549101673
-
Understanding the placebo effect. Part 2: underlying psychological and neurobiological processes
-
Howland RH (2008) Understanding the placebo effect. Part 2: underlying psychological and neurobiological processes. J Psychosoc Nurs Ment Health Serv 46(6):15–18
-
(2008)
J Psychosoc Nurs Ment Health Serv
, vol.46
, Issue.6
, pp. 15-18
-
-
Howland, R.H.1
-
94
-
-
71849111911
-
The placebo-reward hypothesis: dopamine and the placebo effect
-
de la Fuente-Fernandez R (2009) The placebo-reward hypothesis: dopamine and the placebo effect. Parkinsonism Relat Disord 15(3):72–74
-
(2009)
Parkinsonism Relat Disord
, vol.15
, Issue.3
, pp. 72-74
-
-
de la Fuente-Fernandez, R.1
-
95
-
-
85019270779
-
The pharmacology of placebos
-
Wolf S (1959) The pharmacology of placebos. J Am Med Assoc 159:1602–1606
-
(1959)
J Am Med Assoc
, vol.159
, pp. 1602-1606
-
-
Wolf, S.1
-
96
-
-
0033405084
-
The placebo response in Parkinson’s disease. Parkinson Study Group
-
COI: 1:STN:280:DyaK1MzntVygtQ%3D%3D, PID: 10442249
-
Shetty N, Friedman JH, Kieburtz K, Marshall FJ, Oakes D (1999) The placebo response in Parkinson’s disease. Parkinson Study Group. Clin Neuropharmacol 22(4):207–212
-
(1999)
Clin Neuropharmacol
, vol.22
, Issue.4
, pp. 207-212
-
-
Shetty, N.1
Friedman, J.H.2
Kieburtz, K.3
Marshall, F.J.4
Oakes, D.5
-
97
-
-
0035838997
-
Expectation and dopamine release: mechanisms of the placebo effect in Parkinson’s disease
-
PID: 11498597
-
de la Fuente-Fernandez R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ (2001) Expectation and dopamine release: mechanisms of the placebo effect in Parkinson’s disease. Science 293:1164–1166
-
(2001)
Science
, vol.293
, pp. 1164-1166
-
-
de la Fuente-Fernandez, R.1
Ruth, T.J.2
Sossi, V.3
Schulzer, M.4
Calne, D.B.5
Stoessl, A.J.6
-
98
-
-
0037112078
-
Dopamine release in human ventral striatum and expectation of reward
-
PID: 12429397
-
de la Fuente-Fernández R, Phillips AG, Zamburlini M, Sossi V, Calne DB, Ruth TJ, Stoessl AJ (2002) Dopamine release in human ventral striatum and expectation of reward. Behav Brain Res 136(2):359–363
-
(2002)
Behav Brain Res
, vol.136
, Issue.2
, pp. 359-363
-
-
de la Fuente-Fernández, R.1
Phillips, A.G.2
Zamburlini, M.3
Sossi, V.4
Calne, D.B.5
Ruth, T.J.6
Stoessl, A.J.7
-
99
-
-
77955894068
-
Effects of expectation on placebo-induced dopamine release in Parkinson disease
-
COI: 1:CAS:528:DC%2BC3cXhtV2rtrvF, PID: 20679593
-
Lidstone SC, Schulzer M, Dinelle K, Mak E, Sossi V, Ruth TJ, de la Fuente-Fernández R, Phillips AG, Stoessl AJ (2010) Effects of expectation on placebo-induced dopamine release in Parkinson disease. Arch Gen Psychiatry 67(8):857–865
-
(2010)
Arch Gen Psychiatry
, vol.67
, Issue.8
, pp. 857-865
-
-
Lidstone, S.C.1
Schulzer, M.2
Dinelle, K.3
Mak, E.4
Sossi, V.5
Ruth, T.J.6
de la Fuente-Fernández, R.7
Phillips, A.G.8
Stoessl, A.J.9
-
100
-
-
84879929197
-
Treadmill exercise elevates striatal dopamine D2 receptor binding potential in patients with early Parkinson’s disease
-
COI: 1:CAS:528:DC%2BC3sXptVOiu7c%3D, PID: 23636255
-
Fisher BE, Li Q, Nacca A, Salem GJ, Song J, Yip J, Hui JS, Jakowec MW, Petzinger GM (2013) Treadmill exercise elevates striatal dopamine D2 receptor binding potential in patients with early Parkinson’s disease. Neuroreport 24(10):509–514
-
(2013)
Neuroreport
, vol.24
, Issue.10
, pp. 509-514
-
-
Fisher, B.E.1
Li, Q.2
Nacca, A.3
Salem, G.J.4
Song, J.5
Yip, J.6
Hui, J.S.7
Jakowec, M.W.8
Petzinger, G.M.9
|